{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T08:57:36Z","timestamp":1785574656543,"version":"3.56.0"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00203-026-04938-y","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:27:05Z","timestamp":1779182825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidrug-resistant tuberculosis: a comprehensive review of pathogenesis, drug resistance, current treatment and future prospects"],"prefix":"10.1007","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3696-132X","authenticated-orcid":false,"given":"Shweta","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5538-5032","authenticated-orcid":false,"given":"Ankit Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2487-8078","authenticated-orcid":false,"given":"Aarshu","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6742-8796","authenticated-orcid":false,"given":"Joyabroto","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4475-3007","authenticated-orcid":false,"given":"Rashmi Prabha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"7","key":"4938_CR1","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.4049\/jimmunol.0803736","volume":"182","author":"JS Adams","year":"2009","unstructured":"Adams JS, Ren S, Liu PT et al (2009) Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 182(7):4289\u20134295. https:\/\/doi.org\/10.4049\/jimmunol.0803736","journal-title":"J Immunol"},{"issue":"2","key":"4938_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/ijms22020735","volume":"22","author":"A Allu\u00e9-Guardia","year":"2021","unstructured":"Allu\u00e9-Guardia A, Saranathan R, Chan J, Torrelles JB (2021) Mycobacteriophages as potential therapeutic agents against drug-resistant tuberculosis. Int J Mol Sci 22(2):735. https:\/\/doi.org\/10.3390\/ijms22020735","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4938_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000512531","volume":"100","author":"BW Allwood","year":"2021","unstructured":"Allwood BW, Byrne A, Meghji J, Rachow A, Van Der Zalm MM, Schoch OD (2021) Post-tuberculosis lung disease: clinical review of an under-recognised global challenge. Respiration 100(8):8. https:\/\/doi.org\/10.1159\/000512531","journal-title":"Respiration"},{"issue":"2","key":"4938_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.endoen.2016.02.003","volume":"63","author":"CA Amado Diago","year":"2016","unstructured":"Amado Diago CA, Garc\u00eda-Unzueta MT, Fari\u00f1as MDC, Amado JA (2016) Calcitriol-modulated human antibiotics: new pathophysiological aspects of Vitamin D. Endocrinolog\u00eda y Nutrici\u00f3n (English Edition) 63(2):87\u201394. https:\/\/doi.org\/10.1016\/j.endoen.2016.02.003","journal-title":"Endocrinolog\u00eda y Nutrici\u00f3n (English Edition)"},{"key":"4938_CR5","unstructured":"Anonna Dutt. n.d. (2019) Sir Ganga Ram Hospital Starts DOTS Centre for Free TB Treatment, First Private Hospital to Do so in Delhi. (New Delhi). https:\/\/www.hindustantimes.com\/delhi-news\/sir-ganga-ram-hospital-starts-dots-centre-for-free-tb-treatment-first-pvt-hospital-to-do-so-in-city\/story-cukSA94dcLyOF3Wgn74wQL.html"},{"key":"4938_CR168","unstructured":"Anonna Dutt. n.d. (Aug 07, 2019) Sir Ganga Ram Hospital Starts DOTS Centre for Free TB Treatment, First Private Hospital to Do so in Delhi. https:\/\/www.hindustantimes.com\/delhi-news\/sir-ganga-ram-hospital-starts-dots-centre-for-free-tb-treatment-first-pvt-hospital-to-do-so-in-city\/story-cukSA94dcLyOF3Wgn74wQL.html"},{"issue":"1","key":"4938_CR6","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbs1401001","volume":"14","author":"RM Antonello","year":"2022","unstructured":"Antonello RM, Riccardi N (2022) How we deal with Staphylococcus aureus (MSSA, MRSA) central nervous system infections. Front Biosci Schol Ed 14(1):1. https:\/\/doi.org\/10.31083\/j.fbs1401001","journal-title":"Front Biosci Schol Ed"},{"issue":"3","key":"4938_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM et al (2021) Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 20(3):200\u2013216. https:\/\/doi.org\/10.1038\/s41573-020-00114-z","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"4938_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/mmi.13579","volume":"103","author":"LS Ates","year":"2017","unstructured":"Ates LS, Brosch R (2017) <span class=\"SmallCaps\" style=\"font-weight: normal;\">D<\/span>iscovery of the Type VII ESX-1 secretion needle? Mol Microbiol 103(1):7\u201312. https:\/\/doi.org\/10.1111\/mmi.13579","journal-title":"Mol Microbiol"},{"key":"4938_CR9","doi-asserted-by":"publisher","first-page":"595029","DOI":"10.3389\/fcimb.2020.595029","volume":"10","author":"J Augenstreich","year":"2020","unstructured":"Augenstreich J, Briken V (2020) Host Cell Targets of Released Lipid and Secreted Protein Effectors of Mycobacterium Tuberculosis. Front Cell Infect Microbiol 10:595029. https:\/\/doi.org\/10.3389\/fcimb.2020.595029","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4938_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00018-017-2683-x","volume":"75","author":"JA Awuh","year":"2018","unstructured":"Awuh JA, Flo TH (2018) Author correction: molecular basis of mycobacterial survival in macrophages. Cell Mol Life Sci 75(1):161\u2013161. https:\/\/doi.org\/10.1007\/s00018-017-2683-x","journal-title":"Cell Mol Life Sci"},{"key":"4938_CR11","doi-asserted-by":"publisher","first-page":"107287","DOI":"10.1016\/j.micpath.2025.107287","volume":"200","author":"E Aydin","year":"2025","unstructured":"Aydin E, Gunduz MK, Kaymak G et al (2025) Antimycobacterial Activity of Luteolin in Resistant Mycobacterium Tuberculosis Isolates and Cytotoxicity on L929 Cells. Microb Pathog 200:107287. https:\/\/doi.org\/10.1016\/j.micpath.2025.107287","journal-title":"Microb Pathog"},{"issue":"1","key":"4938_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/adpp\/8849786","volume":"2025","author":"KD Ayenew","year":"2025","unstructured":"Ayenew KD, Habteweld HA, Tsige AW, Bizu YS (2025) Novel pharmacological approaches for multidrug-resistant tuberculosis: review. Adv Pharmacol Pharm Sci 2025(1):8849786. https:\/\/doi.org\/10.1155\/adpp\/8849786","journal-title":"Adv Pharmacol Pharm Sci"},{"key":"4938_CR13","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.2147\/IDR.S218638","volume":"12","author":"T Azimi","year":"2019","unstructured":"Azimi T, Mosadegh M, Nasiri MJ, Sabour S, Karimaei S, Nasser A (2019) Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review. Infect Drug Resist 12:2943\u20132959. https:\/\/doi.org\/10.2147\/IDR.S218638","journal-title":"Infect Drug Resist"},{"issue":"5","key":"4938_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001065","volume":"9","author":"S-H Baek","year":"2011","unstructured":"Baek S-H, Li AH, Sassetti CM (2011) Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biol 9(5):e1001065. https:\/\/doi.org\/10.1371\/journal.pbio.1001065","journal-title":"PLoS Biol"},{"key":"4938_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.589318","author":"S Bajeli","year":"2020","unstructured":"Bajeli S, Baid N, Kaur M, Pawar GP, Chaudhari VD, Kumar A (2020) Terminal respiratory oxidases: A targetables vulnerability of mycobacterial bioenergetics? Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2020.589318","journal-title":"Front Cell Infect Microbiol"},{"key":"4938_CR171","doi-asserted-by":"publisher","unstructured":"Bajpai, U., Mehta, A. K., Eniyan, K., Sinha, A., Ray, A., Virdi, S., Ahmad, S., Shah, A., Arora, D., Marwaha, D., Chauhan, G., Saraswat, P., Bathla, P., & Singh, R. (2018) Isolation and characterization of bacteriophages from India, with lytic activity against Mycobacterium tuberculosis. Canadian journal of microbiology, 64(7), 483\u2013491 https:\/\/doi.org\/10.1139\/cjm-2017-0387","DOI":"10.1139\/cjm-2017-0387"},{"key":"4938_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00272-17","author":"D Bald","year":"2017","unstructured":"Bald D, Villellas C, Lu P, Koul A (2017) Targeting energy metabolism in Mycobacterium tuberculosis, a new paradigm in antimycobacterial drug discovery. Mbio 8(2). https:\/\/doi.org\/10.1128\/mbio.00272-17","journal-title":"Mbio"},{"issue":"4","key":"4938_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/biology14040417","volume":"14","author":"O Barazani","year":"2025","unstructured":"Barazani O, Erdos T, Chowdhury R, Kaur G, Venketaraman V (2025) New advances in the development and design of Mycobacterium tuberculosis vaccines: construction and validation of multi-epitope vaccines for tuberculosis prevention. Biology 14(4):417. https:\/\/doi.org\/10.3390\/biology14040417","journal-title":"Biology"},{"issue":"1","key":"4938_CR18","first-page":"1","volume":"58","author":"I Barberis","year":"2017","unstructured":"Barberis I, Bragazzi NL, Galluzzo L, Martini M (2017) The history of tuberculosis: from the first historical records to the isolation of Koch\u2019s Bacillus. J Prev Med Hyg 58(1):1","journal-title":"J Prev Med Hyg"},{"issue":"8","key":"4938_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.05.305","volume":"37","author":"A Barriocanal","year":"2015","unstructured":"Barriocanal A, Arellano AL, Sanz Y et al (2015) Phase I, double-blind, randomized, placebo-controlled clinical trial with the probiotic Nyaditum Resae\u00ae in adults with or without latent tuberculosis infection. Clin Ther 37(8):e106. https:\/\/doi.org\/10.1016\/j.clinthera.2015.05.305","journal-title":"Clin Ther"},{"issue":"12","key":"4938_CR20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrmicro2236","volume":"7","author":"CE Barry","year":"2009","unstructured":"Barry CE, Boshoff HI, Dartois V et al (2009) The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 7(12):845\u2013855. https:\/\/doi.org\/10.1038\/nrmicro2236","journal-title":"Nat Rev Microbiol"},{"key":"4938_CR158","doi-asserted-by":"publisher","unstructured":"Bartolomeu-Gon\u00e7alves, Guilherme, Joyce Marinho De Souza, Bruna Terci Fernandes, et al. (2024)Tuberculosis Diagnosis: Current, Ongoing, and Future Approaches. Diseases 12 (9): 202 https:\/\/doi.org\/10.3390\/diseases12090202","DOI":"10.3390\/diseases12090202"},{"issue":"6","key":"4938_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0025-7125(16)30188-2","volume":"77","author":"JH Bates","year":"1993","unstructured":"Bates JH, Stead WW (1993) The history of tuberculosis as a global epidemic. Med Clin North Am 77(6):6. https:\/\/doi.org\/10.1016\/S0025-7125(16)30188-2","journal-title":"Med Clin North Am"},{"key":"4938_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.tube.2019.05.005","volume":"117","author":"YR Batyrshina","year":"2019","unstructured":"Batyrshina YR, Schwartz YS (2019) Modeling of Mycobacterium tuberculosis dormancy in bacterial cultures. Tuberculosis 117:7\u201317. https:\/\/doi.org\/10.1016\/j.tube.2019.05.005","journal-title":"Tuberculosis"},{"key":"4938_CR160","doi-asserted-by":"publisher","unstructured":"Bedewi Omer, Zufan, Yalemtsehay Mekonnen, Adane Worku, et al. (2016 ) Evaluation of the GenoType MTBDRplus Assay for Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium Tuberculosis Isolates in Central Ethiopia. International Journal of Mycobacteriology 5 (4): 475\u201381 https:\/\/doi.org\/10.1016\/j.ijmyco.2016.06.005","DOI":"10.1016\/j.ijmyco.2016.06.005"},{"issue":"3","key":"4938_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1473-3099(13)70253-6","volume":"14","author":"MA Behr","year":"2014","unstructured":"Behr MA, Waters WR (2014) Is tuberculosis a lymphatic disease with a pulmonary portal? Lancet Infect Dis 14(3):3. https:\/\/doi.org\/10.1016\/S1473-3099(13)70253-6","journal-title":"Lancet Infect Dis"},{"key":"4938_CR24","doi-asserted-by":"publisher","unstructured":"Berns SA, Isakova JA, Pekhtereva PI (2022) The therapeutic potential of interferon-gamma in tuberculosis.\u00a0ADMET and DMPK, ahead of print. https:\/\/doi.org\/10.5599\/admet.1078","DOI":"10.5599\/admet.1078"},{"key":"4938_CR25","doi-asserted-by":"publisher","first-page":"100422","DOI":"10.1016\/j.lansea.2024.100422","volume":"31","author":"A Bhargava","year":"2024","unstructured":"Bhargava A (2024) The 3 HP regimen for tuberculosis preventive treatment: Safety, dosage and related concerns during its large-scale implementation in countries like India. Lancet Reg Health Southeast Asia 31:100422. https:\/\/doi.org\/10.1016\/j.lansea.2024.100422","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"16","key":"4938_CR26","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1089\/ars.2020.8039","volume":"34","author":"VB Borisov","year":"2021","unstructured":"Borisov VB, Siletsky SA, Paiardini A et al (2021) Bacterial oxidases of the Cytochrome Bd Family: redox enzymes of unique structure, function, and utility as drug targets. Antioxid Redox Signal 34(16):1280\u20131318. https:\/\/doi.org\/10.1089\/ars.2020.8039","journal-title":"Antioxid Redox Signal"},{"key":"4938_CR172","doi-asserted-by":"publisher","unstructured":"Borysowski, J., Weber-Dabrowska, B., & G\u00f3rski, A. (2006) Bacteriophage endolysins as a novel class of antibacterial agents. Experimental biology and medicine (Maywood, N.J.), 231(4), 366\u2013377 https:\/\/doi.org\/10.1177\/153537020623100402","DOI":"10.1177\/153537020623100402"},{"key":"4938_CR27","doi-asserted-by":"publisher","unstructured":"Brammachary U, Ramachandra V, Palavesam S, Kapalamurthy VRC, Muralidhar A, Muthaiah M (2025) Mechanisms and action of drug resistance on mycobacterium tuberculosis. In:\u00a0new insights in antibiotic resistance and pneumococcal vaccines, edited by Ghulam Mustafa and Shailendra K. Saxena. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.108943","DOI":"10.5772\/intechopen.108943"},{"key":"4938_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12264","author":"D Brites","year":"2015","unstructured":"Brites D, Gagneux S (2015) Co\u2010evolution of Mycobacterium tuberculosis and Homo sapiens. Immunol Rev 264(1):1. https:\/\/doi.org\/10.1111\/imr.12264","journal-title":"Immunol Rev"},{"key":"4938_CR29","unstructured":"Centers for Disease Control and Prevention (2025) Treatment for TB Disease.\u00a0https:\/\/www.cdc.gov\/tb\/topic\/treatment\/tbdisease.htm#print"},{"key":"4938_CR155","doi-asserted-by":"publisher","unstructured":"Chai, Qiyao, Zhe Lu, and Cui Hua Liu. (2020) Host Defense Mechanisms against Mycobacterium Tuberculosis. Cellular and Molecular Life Sciences 77 (10): 1859\u201378 https:\/\/doi.org\/10.1007\/s00018-019-03353-5","DOI":"10.1007\/s00018-019-03353-5"},{"key":"4938_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12718-4","author":"L Chiaradia","year":"2017","unstructured":"Chiaradia L, Lefebvre C, Parra J et al (2017) Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane. Sci Rep 7(1):12807. https:\/\/doi.org\/10.1038\/s41598-017-12718-4","journal-title":"Sci Rep"},{"key":"4938_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmicr.2024.100295","volume":"7","author":"KL Chin","year":"2024","unstructured":"Chin KL, Anibarro L, Chang ZY et al (2024) Impacts of MDR\/XDR-TB on the global tuberculosis epidemic: challenges and opportunities. Curr Res Microb Sci 7:100295. https:\/\/doi.org\/10.1016\/j.crmicr.2024.100295","journal-title":"Curr Res Microb Sci"},{"issue":"12","key":"4938_CR32","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s00018-015-1862-x","volume":"72","author":"CEL Chua","year":"2015","unstructured":"Chua CEL, Tang BL (2015) Role of Rab GTPases and their interacting proteins in mediating metabolic signalling and regulation. Cell Mol Life Sci 72(12):2289\u20132304. https:\/\/doi.org\/10.1007\/s00018-015-1862-x","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"4938_CR33","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1111\/j.1365-2958.2005.04510.x","volume":"55","author":"R Colangeli","year":"2005","unstructured":"Colangeli R, Helb D, Sridharan S et al (2005) The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both Isoniazid and Ethambutol. Mol Microbiol 55(6):1829\u20131840. https:\/\/doi.org\/10.1111\/j.1365-2958.2005.04510.x","journal-title":"Mol Microbiol"},{"key":"4938_CR166","doi-asserted-by":"publisher","unstructured":"Coulibaly, G., Georges Togo, A. C., Somboro, A. M., Kone, M., Traore, F. G., Diallo, F., Degoga, B., Somboro, A., Dram\u00e9, H. M., Sanogo, M., Kodio, O., Baya, B., Tolofoudie, M., Maiga, A., Maiga, M., Saliba-Shaw, K., Diallo, S., Doumbia, S., Maiga, I. I., Samak\u00e9, F., \u2026 Diarra, B. (2023) Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum as proficient alternative tool in the diagnosis of pulmonary tuberculosis in countries with limited resource settings. International journal of mycobacteriology, 12(2), 144\u2013150 https:\/\/doi.org\/10.4103\/ijmy.ijmy_13_23","DOI":"10.4103\/ijmy.ijmy_13_23"},{"issue":"4","key":"4938_CR34","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1128\/cmr.12.4.564","volume":"12","author":"MM Cowan","year":"1999","unstructured":"Cowan MM (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12(4):564\u2013582. https:\/\/doi.org\/10.1128\/cmr.12.4.564","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"4938_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-695X.2011.00831.x","volume":"63","author":"PEA Da Silva","year":"2011","unstructured":"Da Silva PEA, Von Groll A, Martin A, Palomino JC (2011) Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis\u00a0: Table 1. FEMS Immunol Med Microbiol 63(1):1\u20139. https:\/\/doi.org\/10.1111\/j.1574-695X.2011.00831.x","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"4938_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e02693","volume":"6","author":"N Das","year":"2020","unstructured":"Das N, Jena PK, Pradhan SK (2020) Arabinosyltransferase C enzyme of Mycobacterium tuberculosis, a potential drug target: an insight from molecular docking study. Heliyon 6(2):e02693. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02693","journal-title":"Heliyon"},{"issue":"6","key":"4938_CR37","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1183\/09031936.00124312","volume":"41","author":"S De Lorenzo","year":"2013","unstructured":"De Lorenzo S, Alffenaar JW, Sotgiu G et al (2013) Efficacy and safety of Meropenem\u2013Clavulanate added to Linezolid-containing regimens in the treatment of MDR-\/XDR-TB. Eur Respir J 41(6):1386\u20131392. https:\/\/doi.org\/10.1183\/09031936.00124312","journal-title":"Eur Respir J"},{"key":"4938_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2024.102568","volume":"149","author":"HAK Djunaedy","year":"2024","unstructured":"Djunaedy HAK, Febinia CA, Hamers RL et al (2024) A description of Lineage 1 Mycobacterium tuberculosis from Papua, Indonesia. Tuberculosis 149:102568. https:\/\/doi.org\/10.1016\/j.tube.2024.102568","journal-title":"Tuberculosis"},{"key":"4938_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.151951","author":"J Ferluga","year":"2020","unstructured":"Ferluga J, Yasmin H, Al-Ahdal MN, Bhakta S, Kishore U (2020) Natural and trained innate immunity against Mycobacterium tuberculosis. Immunobiology 225(3):3. https:\/\/doi.org\/10.1016\/j.imbio.2020.151951","journal-title":"Immunobiology"},{"issue":"3","key":"4938_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/mi.2011.14","volume":"4","author":"JL Flynn","year":"2011","unstructured":"Flynn JL, Chan J, Lin PL (2011) Macrophages and control of granulomatous inflammation in Tuberculosis. Mucosal Immunol 4(3):271\u2013278. https:\/\/doi.org\/10.1038\/mi.2011.14","journal-title":"Mucosal Immunol"},{"key":"4938_CR173","doi-asserted-by":"publisher","unstructured":"Gan, Y., Wu, T., Liu, P. et al. (2014) Characterization and classification of Bo4 as a cluster G mycobacteriophage that can infect and lyse M. tuberculosis . Arch Microbiol 196, 209\u2013218 https:\/\/doi.org\/10.1007\/s00203-014-0954-6","DOI":"10.1007\/s00203-014-0954-6"},{"issue":"July","key":"4938_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.tube.2018.05.014","volume":"111","author":"C Genestet","year":"2018","unstructured":"Genestet C, Bernard-Barret F, Hodille E et al (2018) Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophages. Tuberculosis 111(July):67\u201370. https:\/\/doi.org\/10.1016\/j.tube.2018.05.014","journal-title":"Tuberculosis"},{"key":"4938_CR159","doi-asserted-by":"publisher","unstructured":"Georghiou, Sophia B., Margaretha de Vos, Kavindhran Velen, et al. (2023) Designing Molecular Diagnostics for Current Tuberculosis Drug Regimens. Emerging Microbes & Infections 12 (1): 2178243 https:\/\/doi.org\/10.1080\/22221751.2023.2178243","DOI":"10.1080\/22221751.2023.2178243"},{"key":"4938_CR170","doi-asserted-by":"publisher","unstructured":"Ghosh, G., Reddy, J., Sambhare, S., & Sen, R. (2017) A Bacteriophage Capsid Protein Is an Inhibitor of a Conserved Transcription Terminator of Various Bacterial Pathogens. Journal of bacteriology, 200(1), e00380-17 https:\/\/doi.org\/10.1128\/JB.00380-17","DOI":"10.1128\/JB.00380-17"},{"key":"4938_CR42","unstructured":"Global tuberculosis report 2024 (2025)\u00a0https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024.\u00a0Accessed on 19 Feb 2026"},{"issue":"1\u20132","key":"4938_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.tube.2003.08.003","volume":"84","author":"JE Gomez","year":"2004","unstructured":"Gomez JE, McKinney JD (2004) M. Tuberculosis persistence, latency, and drug tolerance. Tuberculosis 84(1\u20132):29\u201344. https:\/\/doi.org\/10.1016\/j.tube.2003.08.003","journal-title":"Tuberculosis"},{"issue":"1","key":"4938_CR44","doi-asserted-by":"publisher","DOI":"10.4103\/bbrj.bbrj_93_17","volume":"2","author":"V Gondil","year":"2018","unstructured":"Gondil V, Chhibber S (2018) Exploring potential of phage therapy for Tuberculosis using model organism. Biomedical Biotechnol Res J (BBRJ) 2(1):9. https:\/\/doi.org\/10.4103\/bbrj.bbrj_93_17","journal-title":"Biomedical Biotechnol Res J (BBRJ)"},{"issue":"11","key":"4938_CR45","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/acsinfecdis.7b00079","volume":"3","author":"P Gopal","year":"2017","unstructured":"Gopal P, Nartey W, Ragunathan P et al (2017) Pyrazinoic acid inhibits mycobacterial Coenzyme A biosynthesis by binding to Aspartate Decarboxylase PanD. ACS Infect Dis 3(11):807\u2013819. https:\/\/doi.org\/10.1021\/acsinfecdis.7b00079","journal-title":"ACS Infect Dis"},{"issue":"4","key":"4938_CR46","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nchembio.794","volume":"8","author":"AE Grzegorzewicz","year":"2012","unstructured":"Grzegorzewicz AE, Pham H, Gundi VAKB et al (2012) Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane. Nat Chem Biol 8(4):334\u2013341. https:\/\/doi.org\/10.1038\/nchembio.794","journal-title":"Nat Chem Biol"},{"issue":"11","key":"4938_CR47","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1128\/AAC.01533-06","volume":"51","author":"T Gumbo","year":"2007","unstructured":"Gumbo T, Louie A, Deziel MR et al (2007) Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by Rifampin. Antimicrob Agents Chemother 51(11):3781\u20133788. https:\/\/doi.org\/10.1128\/AAC.01533-06","journal-title":"Antimicrob Agents Chemother"},{"issue":"14","key":"4938_CR48","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1073\/pnas.1504022112","volume":"112","author":"MB Harbut","year":"2015","unstructured":"Harbut MB, Vilch\u00e8ze C, Luo X et al (2015) Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis. Proc Natl Acad Sci U S A 112(14):4453\u20134458. https:\/\/doi.org\/10.1073\/pnas.1504022112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4938_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.611683","author":"EJ Hasenoehrl","year":"2021","unstructured":"Hasenoehrl EJ, Wiggins TJ, Berney M (2021) Bioenergetic inhibitors: antibiotic efficacy and mechanisms of action in Mycobacterium tuberculosis. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2020.611683","journal-title":"Front Cell Infect Microbiol"},{"key":"4938_CR50","doi-asserted-by":"publisher","unstructured":"Hatami H, Sotgiu G, Bostanghadiri N, et al. (2022) Bedaquiline-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis.J\u00a0Brasileiro de Pneumologia. https:\/\/doi.org\/10.36416\/1806-3756\/e20210384","DOI":"10.36416\/1806-3756\/e20210384"},{"issue":"1","key":"4938_CR51","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s41030-022-00210-y","volume":"9","author":"GF Hatfull","year":"2023","unstructured":"Hatfull GF (2023) Phage therapy for nontuberculous mycobacteria: challenges and opportunities. Pulm Ther 9(1):91\u2013107. https:\/\/doi.org\/10.1007\/s41030-022-00210-y","journal-title":"Pulm Ther"},{"key":"4938_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.tube.2018.05.006","volume":"111","author":"LA Hegeto","year":"2018","unstructured":"Hegeto LA, Caleffi-Ferracioli KR, Nakamura-Vasconcelos SS et al (2018) In vitro combinatory activity of piperine and anti-tuberculosis drugs in Mycobacterium tuberculosis. Tuberculosis Edinb 111:35\u201340. https:\/\/doi.org\/10.1016\/j.tube.2018.05.006","journal-title":"Tuberculosis Edinb"},{"issue":"1","key":"4938_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-2338-5","volume":"15","author":"TTT Hoang","year":"2015","unstructured":"Hoang TTT, Nguyen NV, Dinh SN et al (2015) Challenges in detection and treatment of multidrug resistant tuberculosis patients in Vietnam. BMC Public Health 15(1):980. https:\/\/doi.org\/10.1186\/s12889-015-2338-5","journal-title":"BMC Public Health"},{"issue":"10","key":"4938_CR54","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.tim.2020.04.010","volume":"28","author":"NC Howard","year":"2020","unstructured":"Howard NC, Khader SA (2020) Immunometabolism during Mycobacterium tuberculosis infection. Trends Microbiol 28(10):832\u2013850. https:\/\/doi.org\/10.1016\/j.tim.2020.04.010","journal-title":"Trends Microbiol"},{"key":"4938_CR165","doi-asserted-by":"publisher","unstructured":"Inbaraj, L. R., Daniel, J., Sathya Narayanan, M. K., Srinivasalu, V. A., Bhaskar, A., Scandrett, K., Rajendran, P., Kirubakaran, R., Shewade, H. D., Malaisamy, M., Padmapriyadarsini, C., & Takwoingi, Y. (2025) Truenat MTB assays for pulmonary tuberculosis and rifampicin resistance in adults and adolescents. The Cochrane database of systematic reviews, 3(3), CD015543 https:\/\/doi.org\/10.1002\/14651858.CD015543.pub2","DOI":"10.1002\/14651858.CD015543.pub2"},{"key":"4938_CR167","doi-asserted-by":"publisher","unstructured":"Indirawati, N. N., Yunihastuti, E., Yulianti, M., Nasir, U. Z., Wulandari, D., & Rinaldi, I. (2022) Lateral flow urine lipoarabinomannan assay for extrapulmonary tuberculosis diagnosis in adults who are HIV-positive. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 122, 415\u2013419 https:\/\/doi.org\/10.1016\/j.ijid.2022.06.007","DOI":"10.1016\/j.ijid.2022.06.007"},{"issue":"7","key":"4938_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1073\/pnas.91.7.2428","volume":"91","author":"MD Iseman","year":"1994","unstructured":"Iseman MD (1994) Evolution of drug-resistant tuberculosis: a tale of two species. Proc Natl Acad Sci U S A 91(7):7. https:\/\/doi.org\/10.1073\/pnas.91.7.2428","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4938_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijid.2015.01.001","volume":"32","author":"T Islam","year":"2015","unstructured":"Islam T, Marais BJ, Nhung NV et al (2015) Western Pacific Regional Green Light Committee: progress and way forward. Int J Infect Dis 32:161\u2013165. https:\/\/doi.org\/10.1016\/j.ijid.2015.01.001","journal-title":"Int J Infect Dis"},{"issue":"2","key":"4938_CR57","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1021\/acsinfecdis.2c00283","volume":"9","author":"LN Jeffreys","year":"2023","unstructured":"Jeffreys LN, Ardrey A, Hafiz TA et al (2023) Identification of 2-aryl-quinolone inhibitors of cytochrome Bd and chemical validation of combination strategies for respiratory inhibitors against Mycobacterium tuberculosis. ACS Infect Dis 9(2):221\u2013238. https:\/\/doi.org\/10.1021\/acsinfecdis.2c00283","journal-title":"ACS Infect Dis"},{"issue":"1","key":"4938_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-7-28","volume":"7","author":"L Jeng","year":"2009","unstructured":"Jeng L, Yamshchikov AV, Judd SE et al (2009) Alterations in Vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 7(1):28. https:\/\/doi.org\/10.1186\/1479-5876-7-28","journal-title":"J Transl Med"},{"key":"4938_CR59","doi-asserted-by":"publisher","unstructured":"Jiang L, Wang J, Xu L, Cai J, Zhao S, Ma A (2022) Lactobacillus casei modulates inflammatory cytokines and metabolites during tuberculosis treatment: a post hoc randomized controlled trial.\u00a0Asia Pacific J Clin Nutr\u00a031(1)\u00a0https:\/\/doi.org\/10.6133\/apjcn.202203_31(1).0008.","DOI":"10.6133\/apjcn.202203_31(1).0008"},{"issue":"1","key":"4938_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-023-00387-4","volume":"9","author":"CH Jones","year":"2024","unstructured":"Jones CH, Androsavich JR, So N et al (2024) Breaking the mold with RNA\u2014a \u2018RNAissance\u2019 of life science. Npj Genom Med 9(1):2. https:\/\/doi.org\/10.1038\/s41525-023-00387-4","journal-title":"Npj Genom Med"},{"issue":"12","key":"4938_CR61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1074\/mcp.M111.011445","volume":"10","author":"DS Kelkar","year":"2011","unstructured":"Kelkar DS, Kumar D, Kumar P et al (2011) Proteogenomic analysis of mycobacterium tuberculosis by high resolution mass spectrometry. Molecul Cellul Proteomics MCP 10(12):12. https:\/\/doi.org\/10.1074\/mcp.M111.011445","journal-title":"Molecul Cellul Proteomics MCP"},{"issue":"2","key":"4938_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10381","volume":"8","author":"K Khambhati","year":"2023","unstructured":"Khambhati K, Bhattacharjee G, Gohil N et al (2023) Phage engineering and phage\u2010assisted CRISPR\u2010Cas delivery to combat multidrug\u2010resistant pathogens. Bioeng Transl Med 8(2):e10381. https:\/\/doi.org\/10.1002\/btm2.10381","journal-title":"Bioeng Transl Med"},{"key":"4938_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.cimid.2020.101574","volume":"74","author":"JL Khawbung","year":"2021","unstructured":"Khawbung JL, Nath D, Chakraborty S (2021) Drug resistant tuberculosis: a review. Comp Immunol Microbiol Infect Dis 74:101574. https:\/\/doi.org\/10.1016\/j.cimid.2020.101574","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"1","key":"4938_CR64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40249-016-0214-x","volume":"6","author":"KT Kibret","year":"2017","unstructured":"Kibret KT, Moges Y, Memiah P, Biadgilign S (2017) Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies. Infect Dis Poverty 6(1):7. https:\/\/doi.org\/10.1186\/s40249-016-0214-x","journal-title":"Infect Dis Poverty"},{"issue":"6","key":"4938_CR65","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.tim.2018.02.012","volume":"26","author":"A Koch","year":"2018","unstructured":"Koch A, Mizrahi V (2018) Mycobacterium tuberculosis. Trends Microbiol 26(6):6. https:\/\/doi.org\/10.1016\/j.tim.2018.02.012","journal-title":"Trends Microbiol"},{"key":"4938_CR162","doi-asserted-by":"publisher","unstructured":"Koh, W. J., Ko, Y., Kim, C. K., Park, K. S., & Lee, N. Y. (2012) Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system. Annals of laboratory medicine, 32(4), 264\u2013269 https:\/\/doi.org\/10.3343\/alm.2012.32.4.264","DOI":"10.3343\/alm.2012.32.4.264"},{"issue":"7331","key":"4938_CR66","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature09657","volume":"469","author":"A Koul","year":"2011","unstructured":"Koul A, Arnoult E, Lounis N, Guillemont J, Andries K (2011) The challenge of new drug discovery for tuberculosis. Nature 469(7331):483\u2013490. https:\/\/doi.org\/10.1038\/nature09657","journal-title":"Nature"},{"key":"4938_CR67","doi-asserted-by":"publisher","first-page":"117212","DOI":"10.1016\/j.bmc.2023.117212117212","volume":"81","author":"G Kumar","year":"2023","unstructured":"Kumar G, Kapoor S (2023) Targeting Mycobacterial Membranes and Membrane Proteins: Progress and Limitations. Bioorg Med Chem 81:117212. https:\/\/doi.org\/10.1016\/j.bmc.2023.117212117212","journal-title":"Bioorg Med Chem"},{"key":"4938_CR68","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/j.ijtb.2023.12.003","volume":"71","author":"DS Kumari","year":"2024","unstructured":"Kumari DS, Gupta DA, Chopra DV, Kaur DS (2024) Treatment outcomes of multidrug resistant tuberculosis (MDR TB) treated with bedaquiline under programmatic management of drug resistant tuberculosis at a tertiary care hospital in Punjab, India. Indian J Tuberc 71:S67-71. https:\/\/doi.org\/10.1016\/j.ijtb.2023.12.003","journal-title":"Indian J Tuberc"},{"issue":"27","key":"4938_CR69","doi-asserted-by":"publisher","first-page":"14248","DOI":"10.1074\/jbc.M116.716704","volume":"291","author":"N Lahiri","year":"2016","unstructured":"Lahiri N, Shah RR, Layre E et al (2016) Rifampin Resistance Mutations Are Associated with Broad Chemical Remodeling of Mycobacterium Tuberculosis. J Biol Chem 291(27):14248\u201314256. https:\/\/doi.org\/10.1074\/jbc.M116.716704","journal-title":"J Biol Chem"},{"issue":"1","key":"4938_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12393","volume":"7","author":"DA Lamprecht","year":"2016","unstructured":"Lamprecht DA, Finin PM, Aejazur Rahman M et al (2016) Turning the respiratory flexibility of Mycobacterium tuberculosis against itself. Nat Commun 7(1):12393. https:\/\/doi.org\/10.1038\/ncomms12393","journal-title":"Nat Commun"},{"issue":"1","key":"4938_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00403-5","volume":"22","author":"C Lange","year":"2022","unstructured":"Lange C, Aaby P, Behr MA et al (2022) 100 years of Mycobacterium bovis Bacille Calmette-Gu\u00e9rin. Lancet Infect Dis 22(1):1. https:\/\/doi.org\/10.1016\/S1473-3099(21)00403-5","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"4938_CR71","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/resp.13304","volume":"23","author":"C Lange","year":"2018","unstructured":"Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda K (2018) Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment. Respirology 23(7):656\u2013673. https:\/\/doi.org\/10.1111\/resp.13304","journal-title":"Respirology"},{"key":"4938_CR73","doi-asserted-by":"publisher","first-page":"100294","DOI":"10.1016\/j.lansea.2023.100294","volume":"22","author":"BW Lestari","year":"2024","unstructured":"Lestari BW, Nijman G, Larasmanah A et al (2024) Management of drug-resistant tuberculosis in indonesia: a four-year cascade of care analysis. Lancet Reg Health Southeast Asia 22:100294. https:\/\/doi.org\/10.1016\/j.lansea.2023.100294","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"6","key":"4938_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005675","volume":"12","author":"K Lin","year":"2016","unstructured":"Lin K, O\u2019Brien KM, Trujillo C et al (2016) Mycobacterium tuberculosis thioredoxin reductase is essential for thiol redox homeostasis but plays a minor role in antioxidant defense. PLoS Pathog 12(6):e1005675. https:\/\/doi.org\/10.1371\/journal.ppat.1005675","journal-title":"PLoS Pathog"},{"issue":"1","key":"4938_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/srep28701","volume":"6","author":"Q Li","year":"2016","unstructured":"Li Q, Zhou M, Fan X, Yan J, Li W, Xie J (2016) Mycobacteriophage SWU1 Gp39 can potentiate multiple antibiotics against Mycobacterium via altering the cell wall permeability. Sci Rep 6(1):28701. https:\/\/doi.org\/10.1038\/srep28701","journal-title":"Sci Rep"},{"issue":"6","key":"4938_CR75","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1021\/acsinfecdis.9b00048","volume":"5","author":"W Li","year":"2019","unstructured":"Li W, Stevens CM, Pandya AN et al (2019) Direct inhibition of MmpL3 by novel antitubercular compounds. ACS Infect Dis 5(6):1001\u20131012. https:\/\/doi.org\/10.1021\/acsinfecdis.9b00048","journal-title":"ACS Infect Dis"},{"issue":"Pt 5","key":"4938_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.136827","volume":"282","author":"Y Li","year":"2024","unstructured":"Li Y, Farhan MHR, Yang X et al (2024) A review on the development of bacterial multi-epitope recombinant protein vaccines via reverse vaccinology. Int J Biol Macromol 282(Pt 5):136827. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136827","journal-title":"Int J Biol Macromol"},{"key":"4938_CR78","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.tube.2017.12.002","volume":"109","author":"V Lohrasbi","year":"2018","unstructured":"Lohrasbi V, Talebi M, Bialvaei AZ et al (2018) Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance. Tuberc 109:17\u201327. https:\/\/doi.org\/10.1016\/j.tube.2017.12.002","journal-title":"Tuberc"},{"key":"4938_CR156","doi-asserted-by":"publisher","unstructured":"Louw, G. E., R. M. Warren, N. C. Gey Van Pittius, C. R. E. McEvoy, P. D. Van Helden, and T. C. Victor (2009) A Balancing Act: Efflux\/Influx in Mycobacterial Drug Resistance. Antimicrobial Agents and Chemotherapy 53 (8): 3181\u201389 https:\/\/doi.org\/10.1128\/aac.01577-08","DOI":"10.1128\/aac.01577-08"},{"issue":"1","key":"4938_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/srep10333","volume":"5","author":"P Lu","year":"2015","unstructured":"Lu P, Heineke MH, Koul A et al (2015) The cytochrome Bd-type quinol oxidase is important for survival of Mycobacterium smegmatis under peroxide and antibiotic-induced stress. Sci Rep 5(1):10333. https:\/\/doi.org\/10.1038\/srep10333","journal-title":"Sci Rep"},{"issue":"1","key":"4938_CR80","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TNMI7-0032-2016","volume":"5","author":"SM Lyon","year":"2017","unstructured":"Lyon SM, Rossman MD (2017) Pulmonary tuberculosis. Microbiol Spectr 5(1):1. https:\/\/doi.org\/10.1128\/microbiolspec.TNMI7-0032-2016","journal-title":"Microbiol Spectr"},{"issue":"10","key":"4938_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138976","volume":"10","author":"M Makowska-Grzyska","year":"2015","unstructured":"Makowska-Grzyska M, Kim Y, Gorla SK et al (2015) Mycobacterium tuberculosis IMPDH in complexes with substrates, products and antitubercular compounds. PLoS One 10(10):e0138976. https:\/\/doi.org\/10.1371\/journal.pone.0138976","journal-title":"PLoS One"},{"issue":"1","key":"4938_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0809-5","volume":"15","author":"S Mandal","year":"2017","unstructured":"Mandal S, Chadha VK, Laxminarayan R, Arinaminpathy N (2017) Counting the lives saved by DOTS in India: a model-based approach. BMC Med 15(1):47. https:\/\/doi.org\/10.1186\/s12916-017-0809-5","journal-title":"BMC Med"},{"issue":"4","key":"4938_CR83","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1128\/microbiolspec.GPP3-0067-2019","volume":"7","author":"GT Mashabela","year":"2019","unstructured":"Mashabela GT, De Wet TJ, Warner DF (2019) Mycobacterium tuberculosis metabolism. Microbiol Spectr 7(4):4. https:\/\/doi.org\/10.1128\/microbiolspec.GPP3-0067-2019","journal-title":"Microbiol Spectr"},{"key":"4938_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.980844","author":"MB McNeil","year":"2022","unstructured":"McNeil MB, Cheung C-Y, Waller NJE et al (2022) Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2022.980844","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"4938_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61050911","volume":"61","author":"R Mere\u0161kevi\u010dien\u0117","year":"2025","unstructured":"Mere\u0161kevi\u010dien\u0117 R, Danila E (2025) The adverse effects of tuberculosis treatment: a comprehensive literature review. Medicina (Kaunas) 61(5):911. https:\/\/doi.org\/10.3390\/medicina61050911","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"4938_CR86","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/ng.3195","volume":"47","author":"M Merker","year":"2015","unstructured":"Merker M, Blin C, Mona S et al (2015) Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Nat Genet 47(3):242\u2013249. https:\/\/doi.org\/10.1038\/ng.3195","journal-title":"Nat Genet"},{"key":"4938_CR87","doi-asserted-by":"publisher","unstructured":"Mohamed, Mona S., Miranda Zary, Cedric Kafie, et al. (2024) The impact of digital adherence technologies on health outcomes in tuberculosis: a systematic review and meta-analysis. Prepr Infect Dis (except HIV\/AIDS).\u00a0https:\/\/doi.org\/10.1101\/2024.01.31.24302115","DOI":"10.1101\/2024.01.31.24302115"},{"key":"4938_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2022.105304","volume":"102","author":"BB Monir","year":"2022","unstructured":"Monir BB, Sultana SS, Tarafder S (2022) 24 loci MIRU-VNTR analysis and pattern of drug resistance in pre-extensively drug resistant pulmonary tuberculosis in Bangladesh. Infect Genet Evol 102:105304. https:\/\/doi.org\/10.1016\/j.meegid.2022.105304","journal-title":"Infect Genet Evol"},{"issue":"3","key":"4938_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12030570","volume":"12","author":"S Mtimka","year":"2024","unstructured":"Mtimka S, Pillay P, Kwezi L, Pooe OJ, Tsekoa TL (2024) An exploratory review of the potential of lytic proteins and bacteriophages for the treatment of tuberculosis. Microorganisms 12(3):570. https:\/\/doi.org\/10.3390\/microorganisms12030570","journal-title":"Microorganisms"},{"key":"4938_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00681","volume":"8","author":"MJ Nasiri","year":"2017","unstructured":"Nasiri MJ, Haeili M, Ghazi M et al (2017) New insights in to the intrinsic and acquired drug resistance mechanisms in mycobacteria. Front Microbiol 8:681. https:\/\/doi.org\/10.3389\/fmicb.2017.00681","journal-title":"Front Microbiol"},{"key":"4938_CR91","unstructured":"National TB Elimination Program-NTEP (2025) CP Standards for TB Care in India-Related Treatment for TB. Knowledge base.\u00a0https:\/\/ntep.in\/node\/1590\/CP-standards-tb-care-india-related-treatment-tb."},{"issue":"3","key":"4938_CR92","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01571-17","volume":"62","author":"DA Negatu","year":"2018","unstructured":"Negatu DA, Liu JJJ, Zimmerman M et al (2018) Whole-cell screen of fragment library identifies gut microbiota metabolite Indole Propionic Acid as antitubercular. Antimicrob Agents Chemother 62(3):e01571-17. https:\/\/doi.org\/10.1128\/AAC.01571-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"4938_CR93","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00448-22","volume":"66","author":"TQ Nguyen","year":"2022","unstructured":"Nguyen TQ, Bui TBH, Jeon S et al (2022) Synergistic effect of Q203 combined with PBTZ169 against Mycobacterium tuberculosis. Antimicrob Agents Chemother 66(12):e00448-22. https:\/\/doi.org\/10.1128\/aac.00448-22","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"4938_CR94","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijantimicag.2023.106953","volume":"62","author":"TVA Nguyen","year":"2023","unstructured":"Nguyen TVA, Nguyen QH, Nguyen TNT, Anthony RM, Vu DH, Alffenaar J-W (2023) Pretomanid resistance: an update on emergence, mechanisms and relevance for clinical practice. Int J Antimicrob Agents 62(4):4. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106953","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"4938_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-12056-1","volume":"21","author":"J Nidoi","year":"2021","unstructured":"Nidoi J, Muttamba W, Walusimbi S et al (2021) Impact of socio-economic factors on tuberculosis treatment outcomes in North-Eastern Uganda: a mixed methods study. BMC Public Health 21(1):2167. https:\/\/doi.org\/10.1186\/s12889-021-12056-1","journal-title":"BMC Public Health"},{"key":"4938_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.954074","volume":"12","author":"C Nimmo","year":"2022","unstructured":"Nimmo C, Millard J, Faulkner V, Monteserin J, Pugh H, Johnson EO (2022) Evolution of Mycobacterium tuberculosis drug resistance in the genomic era. Front Cell Infect Microbiol 12:954074. https:\/\/doi.org\/10.3389\/fcimb.2022.954074","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"4938_CR97","doi-asserted-by":"publisher","first-page":"286","DOI":"10.24171\/j.phrp.2024.0026","volume":"15","author":"MF Nugraha","year":"2024","unstructured":"Nugraha MF, Changestu DA, Ramadhan R et al (2024) Novel prophylactic and therapeutic multi-epitope vaccine based on Ag85A, Ag85B, ESAT-6, and CFP-10 of Mycobacterium tuberculosis using an immunoinformatics approach. Osong Public Health Res Perspect 15(4):286\u2013306. https:\/\/doi.org\/10.24171\/j.phrp.2024.0026","journal-title":"Osong Public Health Res Perspect"},{"issue":"1","key":"4938_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-023-04041-5","volume":"23","author":"K Nyambo","year":"2023","unstructured":"Nyambo K, Adu-Amankwaah F, Tapfuma KI et al (2023) In-silico and in-vitro assessments of some Fabaceae, Rhamnaceae, Apocynaceae, and Anacardiaceae species against Mycobacterium tuberculosis H37Rv and triple-negative breast cancer cells. BMC Complement Med Ther 23(1):219. https:\/\/doi.org\/10.1186\/s12906-023-04041-5","journal-title":"BMC Complement Med Ther"},{"issue":"4","key":"4938_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/ph14040323","volume":"14","author":"GS Oliveira","year":"2021","unstructured":"Oliveira GS, Costa RP, Gomes P, Gomes MS, Silva T, Teixeira C (2021) Antimicrobial peptides as potential anti-tubercular leads: a concise review. Pharmaceuticals Basel 14(4):323. https:\/\/doi.org\/10.3390\/ph14040323","journal-title":"Pharmaceuticals Basel"},{"key":"4938_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1277178","volume":"14","author":"X Ouyang","year":"2023","unstructured":"Ouyang X, Li X, Song J et al (2023) Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections. Front Microbiol 14:1277178. https:\/\/doi.org\/10.3389\/fmicb.2023.1277178","journal-title":"Front Microbiol"},{"issue":"11","key":"4938_CR101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047533","volume":"7","author":"O Oxlade","year":"2012","unstructured":"Oxlade O, Murray M (2012) Tuberculosis and poverty: why are the poor at greater risk in India? PLoS One 7(11):e47533. https:\/\/doi.org\/10.1371\/journal.pone.0047533","journal-title":"PLoS One"},{"key":"4938_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.956607","volume":"12","author":"T Parbhoo","year":"2022","unstructured":"Parbhoo T, Mouton JM, Sampson SL (2022) Phenotypic adaptation of Mycobacterium tuberculosis to host-associated stressors that induce persister formation. Front Cell Infect Microbiol 12:956607. https:\/\/doi.org\/10.3389\/fcimb.2022.956607","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"4938_CR103","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1473-3099(09)70330-5","volume":"10","author":"I Parwati","year":"2010","unstructured":"Parwati I, Van Crevel R, Van Soolingen D (2010) Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis 10(2):103\u2013111. https:\/\/doi.org\/10.1016\/S1473-3099(09)70330-5","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"4938_CR104","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1128\/AAC.49.11.4775-4777.2005","volume":"49","author":"MR Pasca","year":"2005","unstructured":"Pasca MR, Guglierame P, De Rossi E, Zara F, Riccardi G (2005) mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis. Antimicrob Agents Chemother 49(11):4775\u20134777. https:\/\/doi.org\/10.1128\/AAC.49.11.4775-4777.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"4938_CR105","unstructured":"Perappadan BS (2024) Health ministry approves new treatment regimen for multidrug-resistant TB.\u00a0The Hindu (New Delhi). https:\/\/www.thehindu.com\/sci-tech\/health\/union-health-ministry-approves-new-treatment-for-multi-drug-resistant-tb\/article68613526.ece."},{"issue":"1","key":"4938_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thorsurg.2018.09.002","volume":"29","author":"AT Pezzella","year":"2019","unstructured":"Pezzella AT (2019) History of pulmonary tuberculosis. Thorac Surg Clin 29(1):1. https:\/\/doi.org\/10.1016\/j.thorsurg.2018.09.002","journal-title":"Thorac Surg Clin"},{"issue":"1","key":"4938_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/lungindia.lungindia_98_17","volume":"35","author":"R Prasad","year":"2018","unstructured":"Prasad R, Gupta N, Banka A (2018) Multidrug-resistant tuberculosis\/rifampicin-resistant tuberculosis: principles of management. Lung India 35(1):1. https:\/\/doi.org\/10.4103\/lungindia.lungindia_98_17","journal-title":"Lung India"},{"issue":"1","key":"4938_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12413-z","volume":"12","author":"MA Rahim","year":"2022","unstructured":"Rahim MA, Seo H, Kim S et al (2022) In vitro anti-tuberculosis effect of probiotic Lacticaseibacillus rhamnosus PMC203 isolated from vaginal microbiota. Sci Rep 12(1):8290. https:\/\/doi.org\/10.1038\/s41598-022-12413-z","journal-title":"Sci Rep"},{"key":"4938_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2025.100618","volume":"15","author":"MF Rahman","year":"2025","unstructured":"Rahman MF, Khan MSI, Huda MM, Mondal UK, Shiddiky MJA, Ross AG (2025) The Global Fund\u2019s Bangladesh program. IJID Regions 15:100618. https:\/\/doi.org\/10.1016\/j.ijregi.2025.100618","journal-title":"IJID Regions"},{"issue":"1","key":"4938_CR110","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1054\/tuld.1998.0002","volume":"79","author":"S Ramaswamy","year":"1998","unstructured":"Ramaswamy S, Musser JM (1998) Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc Lung Dis 79(1):3\u201329. https:\/\/doi.org\/10.1054\/tuld.1998.0002","journal-title":"Tuberc Lung Dis"},{"issue":"12","key":"4938_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22122267","volume":"22","author":"MS Ramirez","year":"2017","unstructured":"Ramirez MS, Tolmasky ME (2017) Amikacin: uses, resistance, and prospects for inhibition. Molecules 22(12):12. https:\/\/doi.org\/10.3390\/molecules22122267","journal-title":"Molecules"},{"issue":"24","key":"4938_CR112","doi-asserted-by":"publisher","first-page":"13881","DOI":"10.1073\/pnas.2235848100","volume":"100","author":"R Rawat","year":"2003","unstructured":"Rawat R, Whitty A, Tonge PJ (2003) The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance. Proc Natl Acad Sci U S A 100(24):13881\u201313886. https:\/\/doi.org\/10.1073\/pnas.2235848100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4938_CR113","doi-asserted-by":"publisher","DOI":"10.15167\/2421-4248\/JPMH2020.61.1S1.1353","author":"N Riccardi","year":"2020","unstructured":"Riccardi N, Canetti D, Martini M et al (2020) The evolution of an ancient disease: tuberculosis discoveries in the centuries. J Prev Med Hyg. https:\/\/doi.org\/10.15167\/2421-4248\/JPMH2020.61.1S1.1353","journal-title":"J Prev Med Hyg"},{"issue":"8","key":"4938_CR114","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/14787210.2020.1760845","volume":"18","author":"L Rodrigues","year":"2020","unstructured":"Rodrigues L, Cravo P, Viveiros M (2020) Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs. Expert Rev Anti Infect Ther 18(8):741\u2013757. https:\/\/doi.org\/10.1080\/14787210.2020.1760845","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"50","key":"4938_CR115","doi-asserted-by":"publisher","first-page":"26271","DOI":"10.1039\/C4RA02142H","volume":"4","author":"DC Rostirolla","year":"2014","unstructured":"Rostirolla DC, De Assun\u00e7\u00e3o TM, Bizarro CV, Basso LA, Santos DS (2014) Biochemical characterization of Mycobacterium tuberculosis IMP dehydrogenase: kinetic mechanism, metal activation and evidence of a cooperative system. RSC Adv 4(50):26271\u201326287. https:\/\/doi.org\/10.1039\/C4RA02142H","journal-title":"RSC Adv"},{"issue":"2","key":"4938_CR116","doi-asserted-by":"publisher","DOI":"10.20473\/jr.v7-I.2.2021.93-99","volume":"7","author":"MID Sanjiwani","year":"2021","unstructured":"Sanjiwani MID, Setiawan NBW, Putra AIYD, Darwinata AE (2021) Probiotic-based therapy for active tuberculosis infection: the role of gut-lung axis and granulocyte macrophage-colony stimulating factor. Jurnal Respirasi 7(2):93. https:\/\/doi.org\/10.20473\/jr.v7-I.2.2021.93-99","journal-title":"Jurnal Respirasi"},{"issue":"14","key":"4938_CR117","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1017\/S0950268818001929","volume":"146","author":"DT Santos","year":"2018","unstructured":"Santos DT, Nunes C, Alves LS et al (2018) Is there association between Human Development Index and tuberculosis mortality risk? Evidence from a spatial analysis study in the south of Brazil. Epidemiol Infect 146(14):1763\u20131770. https:\/\/doi.org\/10.1017\/S0950268818001929","journal-title":"Epidemiol Infect"},{"issue":"1","key":"4938_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-81457-0","volume":"14","author":"A Schami","year":"2024","unstructured":"Schami A, Islam MN, Wall M et al (2024) Drug resistant Mycobacterium tuberculosis strains have altered cell envelope hydrophobicity that influences infection outcomes in human macrophages. Sci Rep 14(1):30840. https:\/\/doi.org\/10.1038\/s41598-024-81457-0","journal-title":"Sci Rep"},{"key":"4938_CR154","doi-asserted-by":"publisher","unstructured":"Seung, Kwonjune J., Salmaan Keshavjee, and Michael L. Rich (2015) Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. Cold Spring Harbor Perspectives in Medicine 5 (9): a017863 https:\/\/doi.org\/10.1101\/cshperspect.a017863","DOI":"10.1101\/cshperspect.a017863"},{"issue":"3","key":"4938_CR119","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01594-21","volume":"10","author":"SK Shanmugam","year":"2022","unstructured":"Shanmugam SK, Kumar N, Sembulingam T et al (2022) Mycobacterium tuberculosis lineages associated with mutations and drug resistance in isolates from India. Microbiol Spectr 10(3):e01594-21. https:\/\/doi.org\/10.1128\/spectrum.01594-21","journal-title":"Microbiol Spectr"},{"key":"4938_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2023.215323","volume":"493","author":"S Shen","year":"2023","unstructured":"Shen S, Shen J, Luo Z, Wang F, Min J (2023) Molecular mechanisms and clinical implications of the gold drug Auranofin. Coord Chem Rev 493:215323. https:\/\/doi.org\/10.1016\/j.ccr.2023.215323","journal-title":"Coord Chem Rev"},{"key":"4938_CR163","unstructured":"Siddiqi, S. H., and R\u00fcsch-Gerdes S. (2006) MGIT Procedure Manual. Geneva, Switzerland https:\/\/www.finddx.org\/wp-content\/uploads\/2023\/02\/20061101_rep_mgit_manual_FV_EN.pdf"},{"issue":"12","key":"4938_CR121","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1128\/JB.187.12.4173-4186.2005","volume":"187","author":"A Singh","year":"2005","unstructured":"Singh A, Gupta R, Vishwakarma RA et al (2005) Requirement of the mymA operon for appropriate cell wall ultrastructure and persistence of Mycobacterium tuberculosis in the spleens of guinea pigs. J Bacteriol 187(12):4173\u20134186. https:\/\/doi.org\/10.1128\/JB.187.12.4173-4186.2005","journal-title":"J Bacteriol"},{"issue":"6","key":"4938_CR123","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04597-22","volume":"11","author":"AK Singh","year":"2023","unstructured":"Singh AK, Gangakhedkar R, Thakur HS, Raman SK, Patil SA, Jain V (2023) Mycobacteriophage D29 Lysin B exhibits promising anti-mycobacterial activity against drug-resistant Mycobacterium tuberculosis. Microbiol Spectr 11(6):e0459722. https:\/\/doi.org\/10.1128\/spectrum.04597-22","journal-title":"Microbiol Spectr"},{"issue":"6","key":"4938_CR122","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2217\/fmb-2017-0135","volume":"13","author":"P Singh","year":"2018","unstructured":"Singh P, Rameshwaram NR, Ghosh S, Mukhopadhyay S (2018) Cell envelope lipids in the pathophysiology of Mycobacterium tuberculosis. Future Microbiol 13(6):689\u2013710. https:\/\/doi.org\/10.2217\/fmb-2017-0135","journal-title":"Future Microbiol"},{"key":"4938_CR157","doi-asserted-by":"publisher","unstructured":"Slail, Mousa J., Rayan Y. Booq, Ibrahim H. Al-Ahmad, et al. (2023) Evaluation of Xpert MTB\/RIF Ultra for the Diagnosis of Extrapulmonary Tuberculosis: A Retrospective Analysis in Saudi Arabia. Journal of Epidemiology and Global Health 13 (4): 782\u201393 https:\/\/doi.org\/10.1007\/s44197-023-00150-z","DOI":"10.1007\/s44197-023-00150-z"},{"issue":"3","key":"4938_CR124","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/CMR.16.3.463-496.2003","volume":"16","author":"I Smith","year":"2003","unstructured":"Smith I (2003) Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 16(3):3. https:\/\/doi.org\/10.1128\/CMR.16.3.463-496.2003","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"4938_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/rr54","volume":"2","author":"A Somoskovi","year":"2001","unstructured":"Somoskovi A, Parsons LM, Salfinger M (2001) The molecular basis of resistance to Isoniazid, Rifampin, and Pyrazinamide in Mycobacterium tuberculosis. Respir Res 2(3):164. https:\/\/doi.org\/10.1186\/rr54","journal-title":"Respir Res"},{"issue":"4","key":"4938_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10040757","volume":"10","author":"E Stewart","year":"2022","unstructured":"Stewart E, Triccas JA, Petrovsky N (2022) Correction: Stewart et al. adjuvant strategies for more effective tuberculosis vaccine immunity. Microorganisms 2019, 7, 255. Microorganisms 10(4):757. https:\/\/doi.org\/10.3390\/microorganisms10040757","journal-title":"Microorganisms"},{"key":"4938_CR169","unstructured":"Sula, L., Sulov\u00e1, J., & Stolcpartov\u00e1, M. (1981) Therapy of experimental tuberculosis in guinea pigs with mycobacterial phages DS-6A, GR-21 T, My-327. Czechoslovak medicine, 4(4), 209\u2013214."},{"issue":"7","key":"4938_CR127","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003499","volume":"9","author":"J Sun","year":"2013","unstructured":"Sun J, Singh V, Lau A et al (2013) Mycobacterium tuberculosis nucleoside diphosphate kinase inactivates small GTPases leading to evasion of innate immunity. PLoS Pathog 9(7):e1003499. https:\/\/doi.org\/10.1371\/journal.ppat.1003499","journal-title":"PLoS Pathog"},{"key":"4938_CR128","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ijid.2022.02.017","volume":"117","author":"CH Suppli","year":"2022","unstructured":"Suppli CH, Norman A, Folkvardsen DB et al (2022) First outbreak of multidrug-resistant tuberculosis (MDR-TB) in Denmark involving six Danish-born cases. Int J Infect Dis 117:258\u2013263. https:\/\/doi.org\/10.1016\/j.ijid.2022.02.017","journal-title":"Int J Infect Dis"},{"issue":"8","key":"4938_CR129","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1016\/j.bmcl.2012.02.053","volume":"22","author":"S Sureram","year":"2012","unstructured":"Sureram S, Senadeera SPD, Hongmanee P, Mahidol C, Ruchirawat S, Kittakoop P (2012) Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis. Bioorg Med Chem Lett 22(8):2902\u20132905. https:\/\/doi.org\/10.1016\/j.bmcl.2012.02.053","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"4938_CR131","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1128\/aac.05708-11","volume":"56","author":"K Tahlan","year":"2012","unstructured":"Tahlan K, Wilson R, Kastrinsky DB et al (2012) SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis. Antimicrob Agents Chemother 56(4):1797\u20131809. https:\/\/doi.org\/10.1128\/aac.05708-11","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4938_CR132","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1128\/AAC.2.1.29","volume":"2","author":"K Takayama","year":"1972","unstructured":"Takayama K, Wang L, David HL (1972) Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2(1):29\u201335. https:\/\/doi.org\/10.1128\/AAC.2.1.29","journal-title":"Antimicrob Agents Chemother"},{"key":"4938_CR130","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.2147\/IJN.S241183","volume":"15","author":"A-F T\u0103b\u0103ran","year":"2020","unstructured":"T\u0103b\u0103ran A-F, Matea CT, Mocan T et al (2020) Silver nanoparticles for the therapy of tuberculosis. Int J Nanomedicine 15:2231\u20132258. https:\/\/doi.org\/10.2147\/IJN.S241183","journal-title":"Int J Nanomedicine"},{"key":"4938_CR133","doi-asserted-by":"publisher","unstructured":"The Lancet Public Health (2023) Taking tuberculosis out of the shadows. Lancet Public Health 8(4):e247. https:\/\/doi.org\/10.1016\/S2468-2667(23)00063-4","DOI":"10.1016\/S2468-2667(23)00063-4"},{"key":"4938_CR161","doi-asserted-by":"publisher","unstructured":"Theron, G., Peter, J., Richardson, M., Warren, R., Dheda, K., & Steingart, K. R. (2016) GenoType\u00ae MTBDRsl assay for resistance to second-line anti-tuberculosis drugs. The Cochrane database of systematic reviews, 9(9), CD010705 https:\/\/doi.org\/10.1002\/14651858.CD010705.pub3","DOI":"10.1002\/14651858.CD010705.pub3"},{"key":"4938_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27616-7","author":"A Torres Ortiz","year":"2021","unstructured":"Torres Ortiz A, Coronel J, Rios Vidal J et al (2021) Genomic signatures of pre-resistance in Mycobacterium tuberculosis. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-021-27616-7","journal-title":"Nat Commun"},{"key":"4938_CR164","doi-asserted-by":"publisher","unstructured":"Tortoli, Enrico, Marta Benedetti, Alessandra Fontanelli, and M. Tullia Simonetti. (2002) Evaluation of Automated BACTEC MGIT 960 System for Testing Susceptibility of Mycobacterium Tuberculosis to Four Major Antituberculous Drugs: Comparison with the Radiometric BACTEC 460TB Method and the Agar Plate Method of Proportion. Journal of Clinical Microbiology 40 (2): 607\u201310 https:\/\/doi.org\/10.1128\/JCM.40.2.607-610.2002","DOI":"10.1128\/JCM.40.2.607-610.2002"},{"issue":"1","key":"4938_CR135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029208","volume":"7","author":"D Ungermannova","year":"2012","unstructured":"Ungermannova D, Parker SJ, Nasveschuk CG et al (2012) Largazole and its derivatives selectively inhibit ubiquitin activating enzyme (E1). PLoS One 7(1):e29208. https:\/\/doi.org\/10.1371\/journal.pone.0029208","journal-title":"PLoS One"},{"key":"4938_CR136","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.meegid.2016.09.004","volume":"45","author":"AN Unissa","year":"2016","unstructured":"Unissa AN, Subbian S, Hanna LE, Selvakumar N (2016) Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis. Infect Genet Evol 45:474\u2013492. https:\/\/doi.org\/10.1016\/j.meegid.2016.09.004","journal-title":"Infect Genet Evol"},{"issue":"1","key":"4938_CR137","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1099\/mic.0.042549-0","volume":"157","author":"V Usha","year":"2011","unstructured":"Usha V, Gurcha SS, Lovering AL et al (2011) Identification of novel diphenyl urea inhibitors of Mt-GuaB2 active against Mycobacterium tuberculosis. Microbiology 157(1):290\u2013299. https:\/\/doi.org\/10.1099\/mic.0.042549-0","journal-title":"Microbiology"},{"issue":"3","key":"4938_CR138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033886","volume":"7","author":"V Usha","year":"2012","unstructured":"Usha V, Hobrath JV, Gurcha SS, Reynolds RC, Besra GS (2012) Identification of novel Mt-Guab2 inhibitor series active against M. tuberculosis. PLoS One 7(3):e33886. https:\/\/doi.org\/10.1371\/journal.pone.0033886","journal-title":"PLoS One"},{"issue":"2","key":"4938_CR139","doi-asserted-by":"publisher","DOI":"10.4103\/ijmy.ijmy_27_20","volume":"9","author":"A Vargas","year":"2020","unstructured":"Vargas A, Rios A, Grandjean L et al (2020) Determination of potentially novel compensatory mutations in Rpoc associated with rifampin resistance and Rpob mutations in Mycobacterium tuberculosis clinical isolates from Peru. Int J Mycobacteriol 9(2):121. https:\/\/doi.org\/10.4103\/ijmy.ijmy_27_20","journal-title":"Int J Mycobacteriol"},{"key":"4938_CR140","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TBTB2-0003-2015","author":"C Vilch\u00e8ze","year":"2017","unstructured":"Vilch\u00e8ze C, Kremer L (2017) Acid-fast positive and acid-fast negative Mycobacterium tuberculosis: the Koch paradox. Microbiol Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.TBTB2-0003-2015","journal-title":"Microbiol Spectr"},{"issue":"1","key":"4938_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00279-z","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang J, Ge P, Qiang L et al (2017) The mycobacterial phosphatase PtpA regulates the expression of host genes and promotes cell proliferation. Nat Commun 8(1):244. https:\/\/doi.org\/10.1038\/s41467-017-00279-z","journal-title":"Nat Commun"},{"key":"4938_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107794","volume":"206","author":"Y Wang","year":"2025","unstructured":"Wang Y, Cao D, Liu G (2025) Application of antimicrobial drugs in Mycobacterium tuberculosis and research progress. Microb Pathog 206:107794. https:\/\/doi.org\/10.1016\/j.micpath.2025.107794","journal-title":"Microb Pathog"},{"key":"4938_CR143","doi-asserted-by":"publisher","unstructured":"Whitney JB and Wainberg MA (2002) Isoniazid, The frontline of resistance in mycobacterium tuberculosis. McGill J Med. https:\/\/doi.org\/10.26443\/mjm.v6i2.686.","DOI":"10.26443\/mjm.v6i2.686"},{"issue":"1","key":"4938_CR144","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0598-2","volume":"14","author":"AA Witney","year":"2016","unstructured":"Witney AA, Cosgrove CA, Arnold A, Hinds J, Stoker NG, Butcher PD (2016) Clinical use of whole genome sequencing for Mycobacterium tuberculosis. BMC Med 14(1):46. https:\/\/doi.org\/10.1186\/s12916-016-0598-2","journal-title":"BMC Med"},{"key":"4938_CR146","unstructured":"World Health Organisation (2016)\u00a0The use of loop-mediated isothermal amplification (TB-LAMP) for the Diagnosis of Pulmonary Tuberculosis: Policy Guidance. Geneva. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK384517\/."},{"key":"4938_CR145","unstructured":"World Health Organisation (WHO) (2025) Global tuberculosis programme data. World Health Organisation. Available at: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/data. Accessed 19 Feb 2026"},{"key":"4938_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2021.102083","volume":"128","author":"G Xu","year":"2021","unstructured":"Xu G, Liu H, Jia X, Wang X, Xu P (2021) Mechanisms and detection methods of Mycobacterium tuberculosis rifampicin resistance: the phenomenon of drug resistance is complex. Tuberculosis (Edinb) 128:102083. https:\/\/doi.org\/10.1016\/j.tube.2021.102083","journal-title":"Tuberculosis (Edinb)"},{"issue":"3","key":"4938_CR148","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3945\/ajcn.2010.29411","volume":"92","author":"AV Yamshchikov","year":"2010","unstructured":"Yamshchikov AV, Kurbatova EV, Kumari M et al (2010) Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am J Clin Nutr 92(3):603\u2013611. https:\/\/doi.org\/10.3945\/ajcn.2010.29411","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"4938_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06006-x","volume":"7","author":"F Yang","year":"2024","unstructured":"Yang F, Labani-Motlagh A, Bohorquez JA et al (2024) Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice. Commun Biol 7(1):294. https:\/\/doi.org\/10.1038\/s42003-024-06006-x","journal-title":"Commun Biol"},{"issue":"6","key":"4938_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12060493","volume":"12","author":"SD Yelamanchi","year":"2022","unstructured":"Yelamanchi SD, Mishra A, Behra SK, Karthikkeyan G, Prasad TSK, Surolia A (2022) Rifampicin-mediated metabolic changes in Mycobacterium tuberculosis. Metabolites 12(6):493. https:\/\/doi.org\/10.3390\/metabo12060493","journal-title":"Metabolites"},{"key":"4938_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1455715","volume":"11","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhao R, Qi Y, Yan X, Qi G, Peng Q (2024) The progress of Mycobacterium tuberculosis drug targets. Front Med 11:1455715. https:\/\/doi.org\/10.3389\/fmed.2024.1455715","journal-title":"Front Med"},{"key":"4938_CR152","doi-asserted-by":"publisher","first-page":"752466","DOI":"10.3389\/fimmu.2021.752466","volume":"12","author":"X Zhou","year":"2022","unstructured":"Zhou X, Lie L, Liang Y et al (2022) GSK-3\u03b1\/\u03b2 activity negatively regulates MMP-1\/9 expression to suppress Mycobacterium tuberculosis infection. Front Immunol 12:752466. https:\/\/doi.org\/10.3389\/fimmu.2021.752466","journal-title":"Front Immunol"},{"issue":"4","key":"4938_CR153","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007011","volume":"14","author":"KE Zulauf","year":"2018","unstructured":"Zulauf KE, Sullivan JT, Braunstein M (2018) The SecA2 pathway of Mycobacterium tuberculosis exports effectors that work in concert to arrest phagosome and autophagosome maturation. PLoS Pathog 14(4):e1007011. https:\/\/doi.org\/10.1371\/journal.ppat.1007011","journal-title":"PLoS Pathog"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04938-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-04938-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04938-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T08:05:44Z","timestamp":1785571544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-04938-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":173,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4938"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-04938-y","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"395"}}